- News
- Biogen
Tag:
Biogen
-
Biogen has agreed to acquire Apellis Pharmaceuticals for approximately $5.6 billion in cash, expanding its portfolio of rare-disease treatments, the companies announced Tuesday.31 Mar 2026-15:50
-
-